Author/Authors :
Rouhi, Azita Student Research Committee - School of Medicine - Shahroud University of Medical Sciences, Shahroud, Iran , Amerian, Monireh Department of Nephrology - Imam Hossain Center for Education - Research and Treatment - Shahroud University of Medical Sciences, Shahroud, Iran , Zolfaghari, Pouneh Vice-chancellery of Health - Shahroud University of Medical Sciences, Shahroud, Iran , Doroudgar, Maryam Vice-chancellery of Health - Shahroud University of Medical Sciences, Shahroud, Iran , Rezaei, Mohammad Ali Department of Internal Medicine - Imam Hossain Center for Education - Research and Treatment - Shahroud University of Medical Sciences, Shahroud, Iran , Sohrabi, Mohammad Bagher School of Medicine - Shahroud University of Medical Sciences, Shahroud, Iran
Abstract :
Background: Malnutrition is common in hemodialysis patients and it
must be controlled quickly. This study aimed to investigate the effect of
zinc sulfate on malnutrition in dialysis patients.
Methods: This study was a randomized controlled trial on 84
hemodialysis patients referred to Imam Hossain hospital in Shahroud
(northeastern of Iran). Patients were randomly divided into two case
and control groups. For the intervention group, one tablet of zinc
sulfate 220 mg was administered daily for 8 weeks. Both groups were
subjected to standard dialysis three times in the week and all patients
were assessed for malnutrition using a standard questionnaire, lab
tests, and necessary examinations in the first stage, one month and two
months after the treatment.
Results: Of 84 patients, 39 cases (46.4%) were female and rest was
male. The mean age of the patients was 59.1±27.2 years. The mean
total duration of dialysis was 2.9±2.3 years. The severity and extent of
malnutrition at the beginning and one month after the study did not
differ between the two groups, but after the second month, there was a
significant decrease of malnutrition in the intervention group
(Pvalue=0.015). Also, malnutrition variables were significantly
associated with BMI less than 18 kg/m2 (Pvalue<0.039), and serum
creatinine less than 3 mg/dl (Pvalue<0.011) and hemoglobin less than
11 g/dl (Pvalue<0.001),
Conclusions: The results of this study showed that zinc sulfate
consumption for at least 2 months could significantly reduce the
severity of malnutrition in hemodialysis patients.